Vice President of Clinical Development and Operati
United States of America
Dr. Starling joined Athersys in 2008 and has served as Vice President of Clinical Development and Operations since January of 2017. He previously served as Senior Director (2008-2016) and Head of Clinical Development and Operations (2014-2016). Dr. Starling oversees the execution of Phase I-III clinical trials including working with external pharmaceutical partners, contract research organizations, and vendors.
Prior to joining Athersys, Dr. Starling served as Associate Director (2001-2006) and Director of Clinical Development (2006-2008) at Pfizer Inc. focusing on Phase II-III clinical trials in osteoporosis, women’s health, and obesity. Prior to his pharmaceutical career, Dr. Starling served as a Research Assistant Professor within the Donald W. Reynolds Department of Geriatrics at the University of Arkansas for Medical Sciences and has over 13 years of experience conducting human interventional trials in an academic setting.